Page last updated: 2024-09-05

bifeprunox and sarizotan

bifeprunox has been researched along with sarizotan in 1 studies

Compound Research Comparison

Studies
(bifeprunox)
Trials
(bifeprunox)
Recent Studies (post-2010)
(bifeprunox)
Studies
(sarizotan)
Trials
(sarizotan)
Recent Studies (post-2010) (sarizotan)
301122675

Protein Interaction Comparison

ProteinTaxonomybifeprunox (IC50)sarizotan (IC50)
5-hydroxytryptamine receptor 1AHomo sapiens (human)0.006
D(2) dopamine receptorHomo sapiens (human)0.006
D(4) dopamine receptorHomo sapiens (human)0.006
D(3) dopamine receptorHomo sapiens (human)0.006
5-hydroxytryptamine receptor 3AHomo sapiens (human)0.006

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bourdiol, N; Colpaert, F; Cuisiat, S; Lacharme, V; Newman-Tancredi, A; Vacher, B1

Other Studies

1 other study(ies) available for bifeprunox and sarizotan

ArticleYear
Towards a new generation of potential antipsychotic agents combining D2 and 5-HT1A receptor activities.
    Journal of medicinal chemistry, 2007, Feb-22, Volume: 50, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Behavior, Animal; Benzofurans; Benzylamines; Dopamine D2 Receptor Antagonists; HeLa Cells; Humans; Radioligand Assay; Rats; Serotonin 5-HT1 Receptor Agonists; Signal Transduction; Stereoisomerism; Structure-Activity Relationship

2007